Ironwood Pharmaceuticals | IRWD - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Agios Pharmaceuticals USD 1.18B 4.3B 2026-03
Akebia Therapeutics 362.52M 357.69M 2026-03
Alnylam Pharmaceuticals USD 69.29M 60.05M 2026-03
Amarin USD 3K 5K 2024-12
Ardelyx USD 5.76M 37K 2025-12
Astellas Pharma JPY 3.91B 320M 2025-03
AstraZeneca USD 484M 181M 2025-12
Charles River Laboratories USD 26.74M 2.97M 2026-03
Coherus Biosciences USD 2.25M 76K 2025-12
Esperion Therapeutics USD 22.64M 585K 2025-12
Halozyme Therapeutics USD 5.51M 597K 2026-03
Incyte USD 569K 13K 2026-03
Ironwood Pharmaceuticals USD 8.74M 506K 2024-12
Karyopharm Therapeutics USD 12.62M 1.24M 2025-12
Lexicon Pharmaceuticals USD 2.03M 124K 2025-12
MacroGenics USD 3.34M 2.54M 2025-09
Moderna USD 11.49B 36B 2026-03
Myriad Genetics USD 4.4M 600K 2025-12
Pacira USD 3.7M 193K 2026-03
PTC Therapeutics USD 2.87B 2.82B 2026-03
Puma Biotechnology USD 3.37M 11K 2024-06
Sarepta Therapeutics USD 20.84M 13.28M 2025-12
Takeda JPY 43.65B 79.98B 2026-03
Ultragenyx Pharmaceutical USD 21M 2M 2026-03
Vanda Pharmaceuticals -1.37B 1.97B 2025-12